Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients

This study has been completed.
Sponsor:
Collaborators:
Institut für Klinische und Molekulare Virologie
University of Erlangen-Nürnberg Medical School
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00284687
First received: January 31, 2006
Last updated: June 9, 2010
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)